Please sign in to follow a disease.

Immunoglobulin A (IgA) nephropathy

Clinical trials for Immunoglobulin A (IgA) nephropathy explained in plain language.

Never miss a new study

Get alerted when new Immunoglobulin A (IgA) nephropathy trials appear

Sign up with your email to follow new studies for Immunoglobulin A (IgA) nephropathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New hope for transplant patients: drug targets kidney protein leak

Disease control Ongoing

This study tests a drug called sparsentan for people who have protein in their urine after a kidney transplant due to IgA nephropathy or FSGS. About 20 adults will take the drug once daily for 36 weeks to see if it safely reduces protein levels and protects kidney function. The g…

Matched conditions: IMMUNOGLOBULIN A (IGA) NEPHROPATHY

Phase 4 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

Immunoglobulin A (IgA) nephropathy

Get alerted when new Immunoglobulin A (IgA) nephropathy trials appear

New hope for transplant patients: drug targets kidney protein leak